Medicaid Provider Information
Pharmacy Provider Drug Utilization Review Board
Per federal law, each state must establish a Drug Use Review (DUR) Board. North Dakota Medicaid's DUR Board has been active for many years. The DUR Board's functions include but are not limited to serving as an advisory board for various policies, identifying and developing educational topics for practitioners to improve drug therapy, and assisting the department in identifying patterns of fraud, abuse, gross overuse, or inappropriate or medically unnecessary care.
The DUR Board includes six physicians, six pharmacists, and three non-voting members as outlined by State Law and Administrative Rules. Meetings are held at least quarterly, and the meetings are open to the public. If you have any questions regarding N.D. Medicaid's DUR Board or the Medication Prior Authorization Program, please contact Brendan Joyce, PharmD, Administrator, Pharmacy Services at email@example.com.
DUR Board members serve staggered three year terms with a maximum of three renewals as described in state law. Below is a table showing the current schedule of the staggered terms and the board members serving those terms. All terms begin July 1 and end June 30 of the specified years. The Position column shows the member subset as well as the entity that appointed that member (e.g. RPh DHS 1 is one of two pharmacists appointed by the Department of Human Services). The number of remaining renewals (if applicable) are shown, and the Appointment Ends column is populated with the year the member would end service on the Board if they exhaust all available renewals.